In silico Identification of Novel Potential BACE-1 Inhibitors for Alzheimer’s Disease Treatment: Molecular Docking, Pharmacophore Modeling and Activity and Synthetic Accessibility Predictions

Journal Title: Journal of Pharmaceutical Research International - Year 2015, Vol 7, Issue 3

Abstract

Aims: Alzheimer's Disease (AD) is a progressive neurodegenerative disease accompanied by loss of memory and cognition. With its causes still unknown, one of the main hypotheses related to its pathogenesis is the amyloidal, where the abnormal metabolism of amyloid precursor protein (APP), in this case cleaved by β-secretase enzyme (BACE-1), generates sAPPβ, subsequent action of β-secretase generates β-amyloid. This gives the β-secretase importance as a therapeutic target of AD, since their inhibition can control the onset and progression of the disease. This work intends to propose three new compounds with inhibitory activity for BACE-1 that may be potential drug candidates for AD treatment. Place and Duration of Study: Laboratory of Modeling and Computational Chemistry (LMCC) at Federal University of Amapá (UNIFAP), Macapá, Brazil, between January 2014 and February 2015. Methodology: First, we selected a group of inhibitors deposited in the BindingDB database as well as a crystallographic protein solved in the Protein Data Bank (PDB). Then we performed a prediction of ligand binding sites of BACE-1. To propose the binding mode of the inhibitor with the enzyme, molecular docking and molecular interactions analyses were performed. New proposals with potential inhibitory activity of BACE-1 in addition to a pharmacophore perception calculation as well as biological activity and synthetic accessibility predictions were made. Results: A group of 40 inhibitors was selected from the database BindingDB, which were submitted to molecular docking simulation (for verification of the possible binding modes with the biological target), when analyzing the results of molecular docking, the hydrogen bond proved dominant over the others (approximately 74%). For pharmacophore perception calculation, the following characteristics were observed: a hydrophobic group, three aromatic groups, three donors and seven hydrogen bond acceptors. The target protein had its regions of the binding site predicted, and the most likely ligand binding site agree with the one already reported in the literature as the catalytic region of BACE-1. This allowed us to model three proposals that, in turn, had their predicted biological activities for BACE-1 as well as their synthetic accessibility. Conclusion: Results showed that the proposals are promising BACE-1 inhibitors, with suitable drug-like properties, for future AD tretament.

Authors and Affiliations

Abraão A. Pinhiero, Karina R. da Silva, Anna E. S. Silva, Francinaldo S. Braga, Carlos H. T. P. da Silva, Cleydson B. R. Santos, Lorane I. S. Hage-Melim

Keywords

Related Articles

Effect of Different Doses of Sitagliptin in Treatment of Experimentally Induced Colitis in Mice

Ulcerative colitis is a chronic, relapsing and progressive inflammatory bowel disease (IBD) characterized by diffused mucosal inflammation of the colon. DPP-IV inhibitors may provide a new treatment strategy for IBD. Thu...

Hospital Pharmacists’ Participation in Multidisciplinary Ward Rounds: Physicians’ Perceptions and Attitudes

Aims: To survey the physicians’ perceptions and attitudes towards pharmacists’ participation in multidisciplinary ward rounds (MDWRs) and to ascertain their acceptance of such practice in the University of Maiduguri Teac...

Comparative Quality Control Evaluation of Atenolol Tablets Marketed in Kuala Lumpur, Malaysia

Background: The emergent of many pharmaceutical companies producing their own generic type of drugs after the patent of innovator drugs expired can improve the general healthcare delivery systems as well as decreasing th...

Effect of Cymbopogon citratus Decoctions on Gasoline Vapour-induced Reproductive Toxicity in Female Rats

Aims: Recent research indicates that plant molecules, particularly those that are rich with antioxidant, anti-inflammatory and immune modulatory constituents, can modify and prevent the detrimental effects of gasoline co...

Anti-bacterial and in vitro Anti-diabetic Potential of Novel Isoxazole Derivatives

Aim: To synthesize novel Isoxazole derivatives, characterize them and subject for screening anti-bacterial action and in vitro anti-diabetic activity. Methodology: Chalcones were prepared by the reaction of aromatic alde...

Download PDF file
  • EP ID EP344450
  • DOI 10.9734/BJPR/2015/18013
  • Views 81
  • Downloads 0

How To Cite

Abraão A. Pinhiero, Karina R. da Silva, Anna E. S. Silva, Francinaldo S. Braga, Carlos H. T. P. da Silva, Cleydson B. R. Santos, Lorane I. S. Hage-Melim (2015). In silico Identification of Novel Potential BACE-1 Inhibitors for Alzheimer’s Disease Treatment: Molecular Docking, Pharmacophore Modeling and Activity and Synthetic Accessibility Predictions. Journal of Pharmaceutical Research International, 7(3), 217-229. https://europub.co.uk/articles/-A-344450